1. K. S. Pang, X. Xu, M. E. Morris, and V. Yuen. Kinetic modeling of conjugations in liver.Fed. Proc. 46:2439–2441 (1987).
2. M. E. Morris and K. S. Pang. Competition between two enzymes for substrate removal in liver: Modulating effects due to substrate recruitment of hepatocyte activity.J. Pharmacokin. Biopharm. 15:473–496 (1987).
3. K. S. Pang, H. Koster, I. C. M. Halsema, E. Scholtens, G. J. Mulder, and R. N. Stillwell. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.J. Pharmacol. Exp. Ther. 224:647–653 (1983).
4. J. R. Dawson, J. G. Weitering, G. J. Mulder, R. N. Stillwell, and K. S. Pang. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.J Pharmacol. Exp. Ther. 234:691–697 (1985).
5. M. E. Morris, V. Yuen, and K. S. Pang. Competing pathways in drug metabolism. II. An identical, anterior enzymic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver.J. Pharmacokin. Biopharm. 16:633–656 (1988).